XS-008

N/A

Report date: 2026/01/04 17:56:06

Base Information

Drug NameXS-008
Drug Alias NameXS008 axitinibAxitinib nanoparticle formulationAmorphous non-crystalline axitinibXS-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsPlatelet-derived growth factor receptor inhibitors
TargetsVascular endothelial growth factor receptorPlatelet-derived growth factor receptor
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXspray Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesXspray Pharma AB
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A